In utero exposure to poly- and perfluoroalkyl substances and children respiratory health in the three first years of life
Poly- and perfluoroalkyl substances (PFAS) are used in a wide range of products. Experimental studies suggested impaired lung development and pro-inflammatory response following exposure to some PFAS. We aimed to assess the associations between prenatal exposure to PFAS and children respiratory heal...
Uloženo v:
| Vydáno v: | Environmental research Ročník 234; s. 116544 |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
Netherlands
Elsevier Inc
01.10.2023
Elsevier |
| Témata: | |
| ISSN: | 0013-9351, 1096-0953, 1096-0953 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Poly- and perfluoroalkyl substances (PFAS) are used in a wide range of products. Experimental studies suggested impaired lung development and pro-inflammatory response following exposure to some PFAS. We aimed to assess the associations between prenatal exposure to PFAS and children respiratory health.
The study is based on 433 mother-child pairs. 26 PFAS were measured in maternal serum collected during pregnancy. Lung function parameters were measured at 2 months using tidal breathing flow-volume loops and multiple-breath nitrogen washout and at 36 months using oscillometry. Incidence of respiratory health diseases (asthma, wheeze, bronchitis, bronchiolitis) in the first 36 months of life was assessed by repeated questionnaires. A cluster-based analysis was applied to identify prenatal PFAS exposure patterns. Adjusted linear and logistic regressions were performed to assess the associations between PFAS exposure patterns as well as individual PFAS, and each respiratory health parameter.
We excluded 13 PFAS due to low quantification (<5%). Relying on the 13 remaining PFAS, we identified three exposure clusters, characterized by low (N = 163), medium (N = 236) and high (N = 51) pregnancy PFAS concentrations. Compared to children belonging to the low exposure group, children in the moderate exposure group had higher reactance at 7 Hz (X7) and lower frequency dependence of resistance between 7 Hz and 19 Hz (R7-19) at 36 months, suggesting better lung function. No association of any exposure metric was detected with respiratory diseases in the first 3 years of life.
Our study relying on both mixture and uni-pollutant analyses, does not provide evidence for a deleterious effect of prenatal PFAS exposure on respiratory health at an early age.
•We measured 13 per- and polyfluoroalkyl substances in maternal serum.•A cluster-based analysis was applied to identify prenatal PFAS exposure patterns.•The moderate exposure group tended to have improved lung function at 36 months.•No association was detected with respiratory diseases in the first 3 years of life.•Overall, our study does not show a deleterious respiratory health effect of PFAS. |
|---|---|
| AbstractList | Poly- and perfluoroalkyl substances (PFAS) are used in a wide range of products. Experimental studies suggested impaired lung development and pro-inflammatory response following exposure to some PFAS. We aimed to assess the associations between prenatal exposure to PFAS and children respiratory health. The study is based on 433 mother-child pairs. 26 PFAS were measured in maternal serum collected during pregnancy. Lung function parameters were measured at 2 months using tidal breathing flow-volume loops and multiple-breath nitrogen washout and at 36 months using oscillometry. Incidence of respiratory health diseases (asthma, wheeze, bronchitis, bronchiolitis) in the first 36 months of life was assessed by repeated questionnaires. A cluster-based analysis was applied to identify prenatal PFAS exposure patterns. Adjusted linear and logistic regressions were performed to assess the associations between PFAS exposure patterns as well as individual PFAS, and each respiratory health parameter. We excluded 13 PFAS due to low quantification (<5%). Relying on the 13 remaining PFAS, we identified three exposure clusters, characterized by low (N = 163), medium (N = 236) and high (N = 51) pregnancy PFAS concentrations. Compared to children belonging to the low exposure group, children in the moderate exposure group had higher reactance at 7 Hz (X₇) and lower frequency dependence of resistance between 7 Hz and 19 Hz (R₇₋₁₉) at 36 months, suggesting better lung function. No association of any exposure metric was detected with respiratory diseases in the first 3 years of life. Our study relying on both mixture and uni-pollutant analyses, does not provide evidence for a deleterious effect of prenatal PFAS exposure on respiratory health at an early age. Poly- and perfluoroalkyl substances (PFAS) are used in a wide range of products. Experimental studies suggested impaired lung development and pro-inflammatory response following exposure to some PFAS. We aimed to assess the associations between prenatal exposure to PFAS and children respiratory health.BACKGROUNDPoly- and perfluoroalkyl substances (PFAS) are used in a wide range of products. Experimental studies suggested impaired lung development and pro-inflammatory response following exposure to some PFAS. We aimed to assess the associations between prenatal exposure to PFAS and children respiratory health.The study is based on 433 mother-child pairs. 26 PFAS were measured in maternal serum collected during pregnancy. Lung function parameters were measured at 2 months using tidal breathing flow-volume loops and multiple-breath nitrogen washout and at 36 months using oscillometry. Incidence of respiratory health diseases (asthma, wheeze, bronchitis, bronchiolitis) in the first 36 months of life was assessed by repeated questionnaires. A cluster-based analysis was applied to identify prenatal PFAS exposure patterns. Adjusted linear and logistic regressions were performed to assess the associations between PFAS exposure patterns as well as individual PFAS, and each respiratory health parameter.METHODSThe study is based on 433 mother-child pairs. 26 PFAS were measured in maternal serum collected during pregnancy. Lung function parameters were measured at 2 months using tidal breathing flow-volume loops and multiple-breath nitrogen washout and at 36 months using oscillometry. Incidence of respiratory health diseases (asthma, wheeze, bronchitis, bronchiolitis) in the first 36 months of life was assessed by repeated questionnaires. A cluster-based analysis was applied to identify prenatal PFAS exposure patterns. Adjusted linear and logistic regressions were performed to assess the associations between PFAS exposure patterns as well as individual PFAS, and each respiratory health parameter.We excluded 13 PFAS due to low quantification (<5%). Relying on the 13 remaining PFAS, we identified three exposure clusters, characterized by low (N = 163), medium (N = 236) and high (N = 51) pregnancy PFAS concentrations. Compared to children belonging to the low exposure group, children in the moderate exposure group had higher reactance at 7 Hz (X7) and lower frequency dependence of resistance between 7 Hz and 19 Hz (R7-19) at 36 months, suggesting better lung function. No association of any exposure metric was detected with respiratory diseases in the first 3 years of life.RESULTSWe excluded 13 PFAS due to low quantification (<5%). Relying on the 13 remaining PFAS, we identified three exposure clusters, characterized by low (N = 163), medium (N = 236) and high (N = 51) pregnancy PFAS concentrations. Compared to children belonging to the low exposure group, children in the moderate exposure group had higher reactance at 7 Hz (X7) and lower frequency dependence of resistance between 7 Hz and 19 Hz (R7-19) at 36 months, suggesting better lung function. No association of any exposure metric was detected with respiratory diseases in the first 3 years of life.Our study relying on both mixture and uni-pollutant analyses, does not provide evidence for a deleterious effect of prenatal PFAS exposure on respiratory health at an early age.CONCLUSIONSOur study relying on both mixture and uni-pollutant analyses, does not provide evidence for a deleterious effect of prenatal PFAS exposure on respiratory health at an early age. Poly- and perfluoroalkyl substances (PFAS) are used in a wide range of products. Experimental studies suggested impaired lung development and pro-inflammatory response following exposure to some PFAS. We aimed to assess the associations between prenatal exposure to PFAS and children respiratory health. The study is based on 433 mother-child pairs. 26 PFAS were measured in maternal serum collected during pregnancy. Lung function parameters were measured at 2 months using tidal breathing flow-volume loops and multiple-breath nitrogen washout and at 36 months using oscillometry. Incidence of respiratory health diseases (asthma, wheeze, bronchitis, bronchiolitis) in the first 36 months of life was assessed by repeated questionnaires. A cluster-based analysis was applied to identify prenatal PFAS exposure patterns. Adjusted linear and logistic regressions were performed to assess the associations between PFAS exposure patterns as well as individual PFAS, and each respiratory health parameter. We excluded 13 PFAS due to low quantification (<5%). Relying on the 13 remaining PFAS, we identified three exposure clusters, characterized by low (N = 163), medium (N = 236) and high (N = 51) pregnancy PFAS concentrations. Compared to children belonging to the low exposure group, children in the moderate exposure group had higher reactance at 7 Hz (X7) and lower frequency dependence of resistance between 7 Hz and 19 Hz (R7-19) at 36 months, suggesting better lung function. No association of any exposure metric was detected with respiratory diseases in the first 3 years of life. Our study relying on both mixture and uni-pollutant analyses, does not provide evidence for a deleterious effect of prenatal PFAS exposure on respiratory health at an early age. •We measured 13 per- and polyfluoroalkyl substances in maternal serum.•A cluster-based analysis was applied to identify prenatal PFAS exposure patterns.•The moderate exposure group tended to have improved lung function at 36 months.•No association was detected with respiratory diseases in the first 3 years of life.•Overall, our study does not show a deleterious respiratory health effect of PFAS. Background: Poly-and perfluoroalkyl substances (PFAS) are used in a wide range of products. Experimental studies suggested impaired lung development and pro-inflammatory response following exposure to some PFAS. We aimed to assess the associations between prenatal exposure to PFAS and children respiratory health. Methods: The study is based on 433 mother-child pairs. 26 PFAS were measured in maternal serum collected during pregnancy. Lung function parameters were measured at 2 months using tidal breathing flow-volume loops and multiple-breath nitrogen washout and at 36 months using oscillometry. Incidence of respiratory health diseases (asthma, wheeze, bronchitis, bronchiolitis) in the first 36 months of life was assessed by repeated questionnaires. A cluster-based analysis was applied to identify prenatal PFAS exposure patterns. Adjusted linear and logistic regressions were performed to assess the associations between PFAS exposure patterns as well as individual PFAS, and each respiratory health parameter. Results: We excluded 13 PFAS due to low quantification (<5%). Relying on the 13 remaining PFAS, we identified three exposure clusters, characterized by low (N = 163), medium (N = 236) and high (N = 51) pregnancy PFAS concentrations. Compared to children belonging to the low exposure group, children in the moderate exposure group had higher reactance at 7 Hz (X 7) and lower frequency dependence of resistance between 7 Hz and 19 Hz (R 7-19) at 36 months, suggesting better lung function. No association of any exposure metric was detected with respiratory diseases in the first 3 years of life. Conclusions: Our study relying on both mixture and uni-pollutant analyses, does not provide evidence for a deleterious effect of prenatal PFAS exposure on respiratory health at an early age. Poly- and perfluoroalkyl substances (PFAS) are used in a wide range of products. Experimental studies suggested impaired lung development and pro-inflammatory response following exposure to some PFAS. We aimed to assess the associations between prenatal exposure to PFAS and children respiratory health. The study is based on 433 mother-child pairs. 26 PFAS were measured in maternal serum collected during pregnancy. Lung function parameters were measured at 2 months using tidal breathing flow-volume loops and multiple-breath nitrogen washout and at 36 months using oscillometry. Incidence of respiratory health diseases (asthma, wheeze, bronchitis, bronchiolitis) in the first 36 months of life was assessed by repeated questionnaires. A cluster-based analysis was applied to identify prenatal PFAS exposure patterns. Adjusted linear and logistic regressions were performed to assess the associations between PFAS exposure patterns as well as individual PFAS, and each respiratory health parameter. We excluded 13 PFAS due to low quantification (<5%). Relying on the 13 remaining PFAS, we identified three exposure clusters, characterized by low (N = 163), medium (N = 236) and high (N = 51) pregnancy PFAS concentrations. Compared to children belonging to the low exposure group, children in the moderate exposure group had higher reactance at 7 Hz (X ) and lower frequency dependence of resistance at 7 Hz and 19 Hz (R ) at 36 months, suggesting better lung function. No association of any exposure metric was detected with respiratory diseases in the first 3 years of life. Our study relying on both mixture and uni-pollutant analyses, does not provide evidence for a deleterious effect of prenatal PFAS exposure on respiratory health at an early age. |
| ArticleNumber | 116544 |
| Author | Coiffier, Ophélie Jovanovic, Nicolas Quentin, Joane Gioria, Yoann Boudier, Anne Philippat, Claire Bayat, Sam Siroux, Valérie Haug, Line Smastuen Slama, Rémy Lyon-Caen, Sarah Thomsen, Cathrine |
| Author_xml | – sequence: 1 givenname: Claire orcidid: 0000-0002-4959-6648 surname: Philippat fullname: Philippat, Claire email: claire.philippat@inserm.fr organization: University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Institute for Advanced Biosciences 38000, Grenoble, France – sequence: 2 givenname: Ophélie surname: Coiffier fullname: Coiffier, Ophélie organization: University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Institute for Advanced Biosciences 38000, Grenoble, France – sequence: 3 givenname: Sarah surname: Lyon-Caen fullname: Lyon-Caen, Sarah organization: University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Institute for Advanced Biosciences 38000, Grenoble, France – sequence: 4 givenname: Anne surname: Boudier fullname: Boudier, Anne organization: University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Institute for Advanced Biosciences 38000, Grenoble, France – sequence: 5 givenname: Nicolas orcidid: 0009-0007-3509-4202 surname: Jovanovic fullname: Jovanovic, Nicolas organization: University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Institute for Advanced Biosciences 38000, Grenoble, France – sequence: 6 givenname: Joane surname: Quentin fullname: Quentin, Joane organization: University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Institute for Advanced Biosciences 38000, Grenoble, France – sequence: 7 givenname: Yoann surname: Gioria fullname: Gioria, Yoann organization: University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Institute for Advanced Biosciences 38000, Grenoble, France – sequence: 8 givenname: Line Smastuen orcidid: 0000-0001-6746-6399 surname: Haug fullname: Haug, Line Smastuen organization: Department of Food Safety, Norwegian Institute of Public Health, Oslo, Norway – sequence: 9 givenname: Cathrine orcidid: 0000-0002-6889-7868 surname: Thomsen fullname: Thomsen, Cathrine organization: Department of Food Safety, Norwegian Institute of Public Health, Oslo, Norway – sequence: 10 givenname: Sam surname: Bayat fullname: Bayat, Sam organization: Department of Pulmonology and Physiology, CHU Grenoble Alpes, Grenoble, France – sequence: 11 givenname: Rémy surname: Slama fullname: Slama, Rémy organization: University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Institute for Advanced Biosciences 38000, Grenoble, France – sequence: 12 givenname: Valérie orcidid: 0000-0001-7329-7237 surname: Siroux fullname: Siroux, Valérie organization: University Grenoble Alpes, Inserm U1209, CNRS UMR 5309, Team of Environmental Epidemiology Applied to Reproduction and Respiratory Health, Institute for Advanced Biosciences 38000, Grenoble, France |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37406719$$D View this record in MEDLINE/PubMed https://hal.science/hal-04302215$$DView record in HAL |
| BookMark | eNqNkc1u1DAURi1URKeFN0DIS1hk8G8cs0CqKqCVRmIDa8vj3CgePHGwnRF5ezKkZcECWF3ZPt-nK58rdDHEARB6ScmWElq_PWxhOCXIW0YY31JaSyGeoA0luq6IlvwCbQihvNJc0kt0lfNhOVLJyTN0yZUgtaJ6g-b7AU8FUsTwY4x5SoBLxGMMc4Xt0OIRUhemmKIN3-aA87TPxQ4O8q9X1_vQJhjwssfoky0xzbgHG0qP_YBLv7T1CQB3PuWCZ7Ap49jh4Dt4jp52NmR48TCv0dePH77c3lW7z5_ub292lRNKlgo4o8AIaCLbRommc5qD6hzoVvI91C2Dva0bxwQoxmrdUCXU3kqoZWu1lPwavVl7exvMmPzRptlE683dzc6c74jghDEqT3RhX6_smOL3CXIxR58dhGAHiFM2rBFaE7KM_0A511qrRi3oqwd02h-h_b3Eo4UFeLcCLsWcE3TG-WKLj0NJ1gdDiTkrNwezKjdn5WZVvoTFH-HH_n_E3q8xWP7-5CGZ7DwsZlufwBXTRv_3gp_rMMfC |
| CitedBy_id | crossref_primary_10_1016_j_envint_2025_109559 crossref_primary_10_1016_j_scitotenv_2024_171742 crossref_primary_10_1016_j_envint_2025_109308 crossref_primary_10_1016_j_banm_2025_03_007 crossref_primary_10_3389_ftox_2024_1423449 crossref_primary_10_1016_j_jhazmat_2025_138485 crossref_primary_10_1183_13993003_02265_2024 crossref_primary_10_1016_j_envres_2025_121814 crossref_primary_10_1016_j_ijheh_2025_114571 crossref_primary_10_1080_10408444_2025_2501420 crossref_primary_10_1186_s12302_025_01122_9 crossref_primary_10_1016_j_jhazmat_2025_137978 crossref_primary_10_3390_bioengineering12040393 crossref_primary_10_7759_cureus_73568 crossref_primary_10_1177_07482337251315216 crossref_primary_10_3390_w17081223 crossref_primary_10_1080_10408444_2025_2546427 |
| Cites_doi | 10.1016/j.envint.2017.01.024 10.1016/j.envres.2017.10.012 10.1002/etc.4935 10.1016/j.envint.2014.01.007 10.1039/D0EM00291G 10.1016/j.reprotox.2010.07.004 10.1016/j.envres.2020.110156 10.1016/j.envres.2020.110145 10.1183/13993003.00753-2019 10.1016/j.envint.2021.106395 10.1016/S2542-5196(19)30010-5 10.1016/j.envint.2018.12.041 10.1016/j.envint.2019.01.010 10.1038/s41370-018-0094-1 10.1021/es303716k 10.1186/s12940-018-0405-y 10.1016/j.chroma.2008.10.113 10.1039/C9EM00502A 10.1016/j.aca.2016.12.043 10.1289/ehp.10896 10.1016/j.envpol.2020.115535 10.1016/j.ijheh.2019.06.005 10.3390/ijerph16203888 10.1016/j.envres.2020.110178 10.1016/j.envint.2020.105979 10.1016/S2213-2600(13)70118-8 |
| ContentType | Journal Article |
| Copyright | 2023 The Authors Copyright © 2023. Published by Elsevier Inc. Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. Distributed under a Creative Commons Attribution 4.0 International License |
| Copyright_xml | – notice: 2023 The Authors – notice: Copyright © 2023. Published by Elsevier Inc. – notice: Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 7S9 L.6 1XC VOOES |
| DOI | 10.1016/j.envres.2023.116544 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | AGRICOLA MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Public Health Environmental Sciences |
| EISSN | 1096-0953 |
| ExternalDocumentID | oai:HAL:hal-04302215v1 37406719 10_1016_j_envres_2023_116544 S0013935123013488 |
| Genre | Journal Article |
| GroupedDBID | --- --K --M -~X .DC .~1 0R~ 1B1 1RT 1~. 1~5 4.4 457 4G. 5GY 5RE 5VS 6I. 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAFTH AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAXUO ABFYP ABJNI ABLST ABMAC ABYKQ ACDAQ ACGFS ACNCT ACRLP ADBBV ADEZE AEBSH AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGYEJ AHEUO AHHHB AIEXJ AIKHN AITUG AJOXV AKIFW ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLECG BLXMC C45 CS3 DM4 DU5 EBS EFBJH EFLBG EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W KCYFY KOM L7B LG5 LY8 M41 MO0 N9A O-L O9- OAUVE OVD OZT P-8 P-9 P2P PC. Q38 RNS ROL RPZ SDF SDG SDP SES SEW SPCBC SSJ SSZ T5K TAE TEORI TN5 TWZ UPT WH7 ZCA ZU3 ~02 ~G- ~KM .GJ 29G 3O- 53G 9DU AAHBH AAQXK AATTM AAXKI AAYJJ AAYWO AAYXX ABEFU ABFNM ABXDB ACLOT ACRPL ACVFH ADCNI ADFGL ADMUD ADNMO ADXHL AEGFY AEIPS AEUPX AFFNX AFJKZ AFPUW AGQPQ AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN CAG CITATION COF EFKBS EJD FEDTE FGOYB G-2 HMC HVGLF HZ~ OHT R2- SEN VOH WUQ XOL XPP ZGI ZKB ZMT ZXP ~HD BNPGV NPM SSH 7X8 7S9 L.6 1XC VOOES |
| ID | FETCH-LOGICAL-c475t-e321e20e905d8748fc93e7fce9d53be6d2eba68c24e7226981747ba5e65da9553 |
| ISICitedReferencesCount | 18 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001046198500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0013-9351 1096-0953 |
| IngestDate | Tue Oct 14 20:49:23 EDT 2025 Sun Sep 28 03:11:22 EDT 2025 Sat Sep 27 21:47:10 EDT 2025 Thu Apr 03 07:05:44 EDT 2025 Sat Nov 29 07:33:01 EST 2025 Tue Nov 18 20:41:44 EST 2025 Fri Feb 23 02:35:26 EST 2024 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Wheeze Polyfluoroalkyl substances Lung function Respiratory health Perfluoroalkyl substances PFAS Oscillometry Asthma |
| Language | English |
| License | This is an open access article under the CC BY-NC license. Copyright © 2023. Published by Elsevier Inc. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c475t-e321e20e905d8748fc93e7fce9d53be6d2eba68c24e7226981747ba5e65da9553 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0001-6746-6399 0000-0001-7329-7237 0000-0002-6889-7868 0000-0002-4959-6648 0009-0007-3509-4202 0000-0002-8565-0293 |
| OpenAccessLink | https://hal.science/hal-04302215 |
| PMID | 37406719 |
| PQID | 2833999787 |
| PQPubID | 23479 |
| ParticipantIDs | hal_primary_oai_HAL_hal_04302215v1 proquest_miscellaneous_2849900284 proquest_miscellaneous_2833999787 pubmed_primary_37406719 crossref_citationtrail_10_1016_j_envres_2023_116544 crossref_primary_10_1016_j_envres_2023_116544 elsevier_sciencedirect_doi_10_1016_j_envres_2023_116544 |
| PublicationCentury | 2000 |
| PublicationDate | 2023-10-01 |
| PublicationDateYYYYMMDD | 2023-10-01 |
| PublicationDate_xml | – month: 10 year: 2023 text: 2023-10-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | Environmental research |
| PublicationTitleAlternate | Environ Res |
| PublicationYear | 2023 |
| Publisher | Elsevier Inc Elsevier |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier |
| References | Grandjean (bib10) 2018; 17 Borg, Bogdanska, Sundström, Nobel, Håkansson, Bergman (bib4) 2010; 30 Goudarzi, Miyashita, Okada, Kashino, Chen, Ito (bib9) 2017; 104 Abellan, Casas (bib1) 2021; 7 Stocks, Hislop, Sonnappa (bib29) 2013; 1 Luo, Deji, Huang (bib19) 2020; 191 Yeung, Robinson, Koschorreck, Mabury (bib31) 2013; 47 Miaz, Plassmann, Gyllenhammar, Bignert, Sandblom, Lignell (bib24) 2020; 22 Mortamais, Chevrier, Philippat, Petit, Calafat, Ye (bib25) 2012; 11 Manzano-Salgado, Granum, Lopez-Espinosa, Ballester, Iñiguez, Gascón (bib22) 2019; 222 Sunderland, Hu, Dassuncao, Tokranov, Wagner, Allen (bib30) 2019; 29 Impinen, Longnecker, Nygaard, London, Ferguson, Haug (bib16) 2019; 124 Ait Bamai, Goudarzi, Araki, Okada, Kashino, Miyashita (bib3) 2020; 143 Lyon-Caen, Siroux, Lepeule, Lorimier, Hainaut, Mossuz (bib20) 2019; 16 Dalsager, Christensen, Halekoh, Timmermann, Nielsen, Kyhl (bib5) 2021; 149 Kung, Lin, Chen, Tsai, Hsieh, Chen (bib18) 2021; 192 Mamsen, Björvang, Mucs, Vinnars, Papadogiannakis, Lindh (bib21) 2019; 124 Huang, Yu, Zeng, Chen, Liu, Zhao (bib14) 2020; 191 DeWitt, Copeland, Strynar, Luebke (bib7) 2008; 116 Poothong, Lundanes, Thomsen, Haug (bib27) 2017; 957 Zhang, Lu, Yu, Yuan, Qin, Li (bib32) 2021; 272 Impinen, Nygaard, Lødrup Carlsen, Mowinckel, Carlsen, Haug (bib15) 2018; 160 Helsel (bib13) 2012 Glüge, Scheringer, Cousins, DeWitt, Goldenman, Herzke (bib8) 2020; 22 King, Bates, Berger, Calverley, de Melo, Dellacà (bib17) 2020; 55 Sørli, Låg, Ekeren, Perez-Gil, Haug, Da Silva (bib28) 2020; 62 Agier, Basagaña, Maitre, Granum, Bird, Casas (bib2) 2019; 3 Gustafsson, Bengtsson, Lindblad, Robinson (bib11) 2017; 123 Haug, Thomsen, Becher (bib12) 2009; 1216 Okada, Sasaki, Kashino, Matsuura, Miyashita, Kobayashi (bib26) 2014; 65 Bates, Schmalisch, Filbrun, Stocks (bib33) 2000; 16 De Silva, Armitage, Bruton, Dassuncao, Heiger-Bernays, Hu (bib6) 2021; 40 Okada (10.1016/j.envres.2023.116544_bib26) 2014; 65 Zhang (10.1016/j.envres.2023.116544_bib32) 2021; 272 Huang (10.1016/j.envres.2023.116544_bib14) 2020; 191 Goudarzi (10.1016/j.envres.2023.116544_bib9) 2017; 104 Haug (10.1016/j.envres.2023.116544_bib12) 2009; 1216 Manzano-Salgado (10.1016/j.envres.2023.116544_bib22) 2019; 222 Impinen (10.1016/j.envres.2023.116544_bib15) 2018; 160 Miaz (10.1016/j.envres.2023.116544_bib24) 2020; 22 Yeung (10.1016/j.envres.2023.116544_bib31) 2013; 47 Luo (10.1016/j.envres.2023.116544_bib19) 2020; 191 Impinen (10.1016/j.envres.2023.116544_bib16) 2019; 124 Abellan (10.1016/j.envres.2023.116544_bib1) 2021; 7 DeWitt (10.1016/j.envres.2023.116544_bib7) 2008; 116 Sørli (10.1016/j.envres.2023.116544_bib28) 2020; 62 Agier (10.1016/j.envres.2023.116544_bib2) 2019; 3 Grandjean (10.1016/j.envres.2023.116544_bib10) 2018; 17 Mortamais (10.1016/j.envres.2023.116544_bib25) 2012; 11 Gustafsson (10.1016/j.envres.2023.116544_bib11) 2017; 123 Borg (10.1016/j.envres.2023.116544_bib4) 2010; 30 Poothong (10.1016/j.envres.2023.116544_bib27) 2017; 957 Glüge (10.1016/j.envres.2023.116544_bib8) 2020; 22 Bates (10.1016/j.envres.2023.116544_bib33) 2000; 16 Helsel (10.1016/j.envres.2023.116544_bib13) 2012 Lyon-Caen (10.1016/j.envres.2023.116544_bib20) 2019; 16 Mamsen (10.1016/j.envres.2023.116544_bib21) 2019; 124 De Silva (10.1016/j.envres.2023.116544_bib6) 2021; 40 King (10.1016/j.envres.2023.116544_bib17) 2020; 55 Ait Bamai (10.1016/j.envres.2023.116544_bib3) 2020; 143 Sunderland (10.1016/j.envres.2023.116544_bib30) 2019; 29 Stocks (10.1016/j.envres.2023.116544_bib29) 2013; 1 Kung (10.1016/j.envres.2023.116544_bib18) 2021; 192 Dalsager (10.1016/j.envres.2023.116544_bib5) 2021; 149 |
| References_xml | – volume: 1 start-page: 728 year: 2013 end-page: 742 ident: bib29 article-title: Early lung development: lifelong effect on respiratory health and disease publication-title: Lancet Respir. Med. – volume: 3 start-page: e81 year: 2019 end-page: e92 ident: bib2 article-title: Early-life exposome and lung function in children in Europe: an analysis of data from the longitudinal, population-based HELIX cohort publication-title: Lancet Planet. Health – volume: 104 start-page: 132 year: 2017 end-page: 138 ident: bib9 article-title: Prenatal exposure to perfluoroalkyl acids and prevalence of infectious diseases up to 4 years of age publication-title: Environ. Int. – volume: 272 year: 2021 ident: bib32 article-title: Effects of gestational exposure to perfluorooctane sulfonate on the lung development of offspring rats publication-title: Environ. Pollut. – volume: 123 start-page: 1545 year: 2017 end-page: 1554 ident: bib11 article-title: The effect of inert gas choice on multiple breath washout in healthy infants: differences in lung function outcomes and breathing pattern publication-title: J Appl Physiol Bethesda Md 1985 – volume: 55 year: 2020 ident: bib17 article-title: Technical standards for respiratory oscillometry publication-title: Eur. Respir. J. – volume: 192 year: 2021 ident: bib18 article-title: Intrauterine exposure to per- and polyfluoroalkyl substances may harm children's lung function development publication-title: Environ. Res. – volume: 17 start-page: 62 year: 2018 ident: bib10 article-title: Delayed discovery, dissemination, and decisions on intervention in environmental health: a case study on immunotoxicity of perfluorinated alkylate substances publication-title: Environ. Health – volume: 957 start-page: 10 year: 2017 end-page: 19 ident: bib27 article-title: High throughput online solid phase extraction-ultra high performance liquid chromatography-tandem mass spectrometry method for polyfluoroalkyl phosphate esters, perfluoroalkyl phosphonates, and other perfluoroalkyl substances in human serum, plasma, and whole blood publication-title: Anal. Chim. Acta – volume: 29 start-page: 131 year: 2019 end-page: 147 ident: bib30 article-title: A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects publication-title: J. Expo. Sci. Environ. Epidemiol. – volume: 124 start-page: 482 year: 2019 end-page: 492 ident: bib21 article-title: Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies publication-title: Environ. Int. – volume: 116 start-page: 644 year: 2008 end-page: 650 ident: bib7 article-title: Perfluorooctanoic acid–induced immunomodulation in adult C57bl/6J or C57bl/6N female mice publication-title: Environ Health Perspect. Environmental Health Perspectives – volume: 124 start-page: 462 year: 2019 end-page: 472 ident: bib16 article-title: Maternal levels of perfluoroalkyl substances (PFASs) during pregnancy and childhood allergy and asthma related outcomes and infections in the Norwegian Mother and Child (MoBa) cohort publication-title: Environ. Int. – volume: 47 start-page: 3865 year: 2013 end-page: 3874 ident: bib31 article-title: Part I. A temporal study of PFCAs and their precursors in human plasma from two German cities 1982-2009 publication-title: Environ. Sci. Technol. – volume: 22 start-page: 1071 year: 2020 end-page: 1083 ident: bib24 article-title: Temporal trends of suspect- and target-per/polyfluoroalkyl substances (PFAS), extractable organic fluorine (EOF) and total fluorine (TF) in pooled serum from first-time mothers in Uppsala, Sweden, 1996-2017 publication-title: Environ Sci Process Impacts – volume: 65 start-page: 127 year: 2014 end-page: 134 ident: bib26 article-title: Prenatal exposure to perfluoroalkyl acids and allergic diseases in early childhood publication-title: Environ. Int. – volume: 7 start-page: 6293 year: 2021 ident: bib1 article-title: In utero exposure to organic pollutants and lung function in the offspring publication-title: Barc Respir Netw – volume: 149 year: 2021 ident: bib5 article-title: Exposure to perfluoroalkyl substances during fetal life and hospitalization for infectious disease in childhood: a study among 1,503 children from the Odense Child Cohort publication-title: Environ. Int. – volume: 222 start-page: 945 year: 2019 end-page: 954 ident: bib22 article-title: Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study publication-title: Int. J. Hyg Environ. Health – volume: 160 start-page: 518 year: 2018 end-page: 523 ident: bib15 article-title: Prenatal exposure to perfluoralkyl substances (PFASs) associated with respiratory tract infections but not allergy- and asthma-related health outcomes in childhood publication-title: Environ. Res. – volume: 40 start-page: 631 year: 2021 end-page: 657 ident: bib6 article-title: PFAS exposure pathways for humans and wildlife: a synthesis of current knowledge and key gaps in understanding publication-title: Environ. Toxicol. Chem. – volume: 62 year: 2020 ident: bib28 article-title: Per- and polyfluoroalkyl substances (PFASs) modify lung surfactant function and pro-inflammatory responses in human bronchial epithelial cells publication-title: Toxicol Vitro Int J Publ Assoc BIBRA – volume: 191 year: 2020 ident: bib14 article-title: Association between prenatal exposure to perfluoroalkyl substances and respiratory tract infections in preschool children publication-title: Environ. Res. – volume: 22 start-page: 2345 year: 2020 end-page: 2373 ident: bib8 article-title: An overview of the uses of per- and polyfluoroalkyl substances (PFAS) publication-title: Environ Sci Process Impacts – volume: 1216 start-page: 385 year: 2009 end-page: 393 ident: bib12 article-title: A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring publication-title: J. Chromatogr. A – volume: 16 start-page: E3888 year: 2019 ident: bib20 article-title: Deciphering the impact of early-life exposures to highly variable environmental factors on foetal and child health: design of SEPAGES couple-child cohort publication-title: Int. J. Environ. Res. Publ. Health – volume: 11 start-page: 29 year: 2012 ident: bib25 article-title: Correcting for the influence of sampling conditions on biomarkers of exposure to phenols and phthalates: a 2-step standardization method based on regression residuals publication-title: Environ. Health (Lond.) – volume: 30 start-page: 558 year: 2010 end-page: 565 ident: bib4 article-title: Tissue distribution of (35)S-labelled perfluorooctane sulfonate (PFOS) in C57Bl/6 mice following late gestational exposure publication-title: Reprod Toxicol Elmsford N – volume: 191 year: 2020 ident: bib19 article-title: Exposure to perfluoroalkyl substances and allergic outcomes in children: a systematic review and meta-analysis publication-title: Environ. Res. – volume: 16 start-page: 1180 year: 2000 end-page: 1192 ident: bib33 article-title: Tidal breath analysis for infant pulmonary function testing. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing publication-title: European Respiratory Society/American Thoracic Society. Eur. Respir. J. – volume: 143 year: 2020 ident: bib3 article-title: Effect of prenatal exposure to per- and polyfluoroalkyl substances on childhood allergies and common infectious diseases in children up to age 7 years: the Hokkaido study on environment and children's health publication-title: Environ. Int. – year: 2012 ident: bib13 article-title: Statistics for Censored Environmental Data Using Minitab and R – volume: 104 start-page: 132 year: 2017 ident: 10.1016/j.envres.2023.116544_bib9 article-title: Prenatal exposure to perfluoroalkyl acids and prevalence of infectious diseases up to 4 years of age publication-title: Environ. Int. doi: 10.1016/j.envint.2017.01.024 – volume: 160 start-page: 518 year: 2018 ident: 10.1016/j.envres.2023.116544_bib15 article-title: Prenatal exposure to perfluoralkyl substances (PFASs) associated with respiratory tract infections but not allergy- and asthma-related health outcomes in childhood publication-title: Environ. Res. doi: 10.1016/j.envres.2017.10.012 – volume: 40 start-page: 631 year: 2021 ident: 10.1016/j.envres.2023.116544_bib6 article-title: PFAS exposure pathways for humans and wildlife: a synthesis of current knowledge and key gaps in understanding publication-title: Environ. Toxicol. Chem. doi: 10.1002/etc.4935 – volume: 65 start-page: 127 year: 2014 ident: 10.1016/j.envres.2023.116544_bib26 article-title: Prenatal exposure to perfluoroalkyl acids and allergic diseases in early childhood publication-title: Environ. Int. doi: 10.1016/j.envint.2014.01.007 – volume: 62 year: 2020 ident: 10.1016/j.envres.2023.116544_bib28 article-title: Per- and polyfluoroalkyl substances (PFASs) modify lung surfactant function and pro-inflammatory responses in human bronchial epithelial cells publication-title: Toxicol Vitro Int J Publ Assoc BIBRA – volume: 22 start-page: 2345 year: 2020 ident: 10.1016/j.envres.2023.116544_bib8 article-title: An overview of the uses of per- and polyfluoroalkyl substances (PFAS) publication-title: Environ Sci Process Impacts doi: 10.1039/D0EM00291G – volume: 30 start-page: 558 year: 2010 ident: 10.1016/j.envres.2023.116544_bib4 article-title: Tissue distribution of (35)S-labelled perfluorooctane sulfonate (PFOS) in C57Bl/6 mice following late gestational exposure publication-title: Reprod Toxicol Elmsford N doi: 10.1016/j.reprotox.2010.07.004 – volume: 123 start-page: 1545 year: 2017 ident: 10.1016/j.envres.2023.116544_bib11 article-title: The effect of inert gas choice on multiple breath washout in healthy infants: differences in lung function outcomes and breathing pattern publication-title: J Appl Physiol Bethesda Md 1985 – volume: 191 year: 2020 ident: 10.1016/j.envres.2023.116544_bib14 article-title: Association between prenatal exposure to perfluoroalkyl substances and respiratory tract infections in preschool children publication-title: Environ. Res. doi: 10.1016/j.envres.2020.110156 – volume: 191 year: 2020 ident: 10.1016/j.envres.2023.116544_bib19 article-title: Exposure to perfluoroalkyl substances and allergic outcomes in children: a systematic review and meta-analysis publication-title: Environ. Res. doi: 10.1016/j.envres.2020.110145 – volume: 16 start-page: 1180 year: 2000 ident: 10.1016/j.envres.2023.116544_bib33 article-title: Tidal breath analysis for infant pulmonary function testing. ERS/ATS Task Force on Standards for Infant Respiratory Function Testing publication-title: European Respiratory Society/American Thoracic Society. Eur. Respir. J. – volume: 7 start-page: 6293 year: 2021 ident: 10.1016/j.envres.2023.116544_bib1 article-title: In utero exposure to organic pollutants and lung function in the offspring publication-title: Barc Respir Netw – volume: 55 year: 2020 ident: 10.1016/j.envres.2023.116544_bib17 article-title: Technical standards for respiratory oscillometry publication-title: Eur. Respir. J. doi: 10.1183/13993003.00753-2019 – volume: 149 year: 2021 ident: 10.1016/j.envres.2023.116544_bib5 article-title: Exposure to perfluoroalkyl substances during fetal life and hospitalization for infectious disease in childhood: a study among 1,503 children from the Odense Child Cohort publication-title: Environ. Int. doi: 10.1016/j.envint.2021.106395 – volume: 3 start-page: e81 year: 2019 ident: 10.1016/j.envres.2023.116544_bib2 article-title: Early-life exposome and lung function in children in Europe: an analysis of data from the longitudinal, population-based HELIX cohort publication-title: Lancet Planet. Health doi: 10.1016/S2542-5196(19)30010-5 – year: 2012 ident: 10.1016/j.envres.2023.116544_bib13 – volume: 124 start-page: 462 year: 2019 ident: 10.1016/j.envres.2023.116544_bib16 article-title: Maternal levels of perfluoroalkyl substances (PFASs) during pregnancy and childhood allergy and asthma related outcomes and infections in the Norwegian Mother and Child (MoBa) cohort publication-title: Environ. Int. doi: 10.1016/j.envint.2018.12.041 – volume: 124 start-page: 482 year: 2019 ident: 10.1016/j.envres.2023.116544_bib21 article-title: Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies publication-title: Environ. Int. doi: 10.1016/j.envint.2019.01.010 – volume: 29 start-page: 131 year: 2019 ident: 10.1016/j.envres.2023.116544_bib30 article-title: A review of the pathways of human exposure to poly- and perfluoroalkyl substances (PFASs) and present understanding of health effects publication-title: J. Expo. Sci. Environ. Epidemiol. doi: 10.1038/s41370-018-0094-1 – volume: 47 start-page: 3865 year: 2013 ident: 10.1016/j.envres.2023.116544_bib31 article-title: Part I. A temporal study of PFCAs and their precursors in human plasma from two German cities 1982-2009 publication-title: Environ. Sci. Technol. doi: 10.1021/es303716k – volume: 17 start-page: 62 year: 2018 ident: 10.1016/j.envres.2023.116544_bib10 article-title: Delayed discovery, dissemination, and decisions on intervention in environmental health: a case study on immunotoxicity of perfluorinated alkylate substances publication-title: Environ. Health doi: 10.1186/s12940-018-0405-y – volume: 1216 start-page: 385 year: 2009 ident: 10.1016/j.envres.2023.116544_bib12 article-title: A sensitive method for determination of a broad range of perfluorinated compounds in serum suitable for large-scale human biomonitoring publication-title: J. Chromatogr. A doi: 10.1016/j.chroma.2008.10.113 – volume: 22 start-page: 1071 year: 2020 ident: 10.1016/j.envres.2023.116544_bib24 article-title: Temporal trends of suspect- and target-per/polyfluoroalkyl substances (PFAS), extractable organic fluorine (EOF) and total fluorine (TF) in pooled serum from first-time mothers in Uppsala, Sweden, 1996-2017 publication-title: Environ Sci Process Impacts doi: 10.1039/C9EM00502A – volume: 957 start-page: 10 year: 2017 ident: 10.1016/j.envres.2023.116544_bib27 publication-title: Anal. Chim. Acta doi: 10.1016/j.aca.2016.12.043 – volume: 116 start-page: 644 year: 2008 ident: 10.1016/j.envres.2023.116544_bib7 article-title: Perfluorooctanoic acid–induced immunomodulation in adult C57bl/6J or C57bl/6N female mice publication-title: Environ Health Perspect. Environmental Health Perspectives doi: 10.1289/ehp.10896 – volume: 272 year: 2021 ident: 10.1016/j.envres.2023.116544_bib32 article-title: Effects of gestational exposure to perfluorooctane sulfonate on the lung development of offspring rats publication-title: Environ. Pollut. doi: 10.1016/j.envpol.2020.115535 – volume: 222 start-page: 945 year: 2019 ident: 10.1016/j.envres.2023.116544_bib22 article-title: Prenatal exposure to perfluoroalkyl substances, immune-related outcomes, and lung function in children from a Spanish birth cohort study publication-title: Int. J. Hyg Environ. Health doi: 10.1016/j.ijheh.2019.06.005 – volume: 16 start-page: E3888 year: 2019 ident: 10.1016/j.envres.2023.116544_bib20 article-title: Deciphering the impact of early-life exposures to highly variable environmental factors on foetal and child health: design of SEPAGES couple-child cohort publication-title: Int. J. Environ. Res. Publ. Health doi: 10.3390/ijerph16203888 – volume: 192 year: 2021 ident: 10.1016/j.envres.2023.116544_bib18 article-title: Intrauterine exposure to per- and polyfluoroalkyl substances may harm children's lung function development publication-title: Environ. Res. doi: 10.1016/j.envres.2020.110178 – volume: 11 start-page: 29 year: 2012 ident: 10.1016/j.envres.2023.116544_bib25 article-title: Correcting for the influence of sampling conditions on biomarkers of exposure to phenols and phthalates: a 2-step standardization method based on regression residuals publication-title: Environ. Health (Lond.) – volume: 143 year: 2020 ident: 10.1016/j.envres.2023.116544_bib3 article-title: Effect of prenatal exposure to per- and polyfluoroalkyl substances on childhood allergies and common infectious diseases in children up to age 7 years: the Hokkaido study on environment and children's health publication-title: Environ. Int. doi: 10.1016/j.envint.2020.105979 – volume: 1 start-page: 728 year: 2013 ident: 10.1016/j.envres.2023.116544_bib29 article-title: Early lung development: lifelong effect on respiratory health and disease publication-title: Lancet Respir. Med. doi: 10.1016/S2213-2600(13)70118-8 |
| SSID | ssj0011530 |
| Score | 2.4885879 |
| Snippet | Poly- and perfluoroalkyl substances (PFAS) are used in a wide range of products. Experimental studies suggested impaired lung development and pro-inflammatory... Background: Poly-and perfluoroalkyl substances (PFAS) are used in a wide range of products. Experimental studies suggested impaired lung development and... |
| SourceID | hal proquest pubmed crossref elsevier |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 116544 |
| SubjectTerms | Asthma blood serum bronchiolitis Human health and pathology inflammation Life Sciences Lung function lungs maternal exposure nitrogen Oscillometry Perfluoroalkyl substances perfluorocarbons PFAS Polyfluoroalkyl substances pregnancy Pulmonology and respiratory tract Respiratory health Santé publique et épidémiologie Wheeze |
| Title | In utero exposure to poly- and perfluoroalkyl substances and children respiratory health in the three first years of life |
| URI | https://dx.doi.org/10.1016/j.envres.2023.116544 https://www.ncbi.nlm.nih.gov/pubmed/37406719 https://www.proquest.com/docview/2833999787 https://www.proquest.com/docview/2849900284 https://hal.science/hal-04302215 |
| Volume | 234 |
| WOSCitedRecordID | wos001046198500001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1096-0953 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0011530 issn: 0013-9351 databaseCode: AIEXJ dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9swEBdJO0ZhjK1bt-yjaGNvwcHxR2Q9ZiGjGaHbQwd5M_6QqVtPMokTmv-hf3RPkuUkhKzbw15MsGyJ6Pfz6e50d0LoS-AQEntOZvUpcywvAQMlSqPA8lKvzzxYsdxUlcyfksvLYDajP1ute5MLsyoI58HdHS3_K9RwD8CWqbP_AHfTKdyA3wA6XAF2uP4V8BPelcc0CFm8X0j_n1QvS1GsLV0UgM2zYinmIipu10V3AYKjksjrWs1Nbvd8awte50qaiMgK0GfdLAe1sbuGyVOxIEWe7cQUjTf5c-rkgC2fWb0FkZdlpENOimgrAnckpBNJ8-hHea338Yu8aZ-uBbdGkRaWO-7sr0JGROqzuXkdLFC7M5xNYBysRloE2zIsmvrulliVNYJ0mcg9ia-dDzc9xlfwZ3qyy97-4wBR-VsB7hJQYUgtpncrbZumNjp2iE9BRh4PJ-PZ92ZXClYH26RfqhjB_UFP0FPTzSFNp30tQ24P2TNKr7l6gZ7XBgkeaiK9RC3GT9HZDn64XgAWp-iZdvNinb32Cq0nHCu2YcM2XAms2IaBT3iXbXjDNtVq2Ia32IY123DOMbANK7ZhxTas2IZFhiXbXqNf38ZXowurPs3DSjziVxZznT5zbEZtPw2IF2QJdRnJEkZT343ZIHVYHA2CxPEYAZuABmArkzjy2cBPI-r77hk64oKztwhHtpfaDJTlGAyONJBGu5_FjJJ-7LoDO-0g18x8mNSl7uWJK0VoYhpvQg1dKKELNXQdZDVvlbrUyyPPEwNqWKurWg0NgZuPvPkZONAMIiu8XwynobwnS_A5oIav-h30yVAkBJEv9_EizsQSegpcMCsoLLV_egZmRTpUYLA3ml_NeIag7w62vEcnm2_zAzqq5kv2ET1JVlW-mJ-jNpkF5_XH8QAPv-Dn |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+utero+exposure+to+poly-+and+perfluoroalkyl+substances+and+children+respiratory+health+in+the+three+first+years+of+life&rft.jtitle=Environmental+research&rft.au=Philippat%2C+Claire&rft.au=Coiffier%2C+Oph%C3%A9lie&rft.au=Lyon-Caen%2C+Sarah&rft.au=Boudier%2C+Anne&rft.date=2023-10-01&rft.eissn=1096-0953&rft.spage=116544&rft_id=info:doi/10.1016%2Fj.envres.2023.116544&rft_id=info%3Apmid%2F37406719&rft.externalDocID=37406719 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0013-9351&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0013-9351&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0013-9351&client=summon |